Antiplatelet Therapy
Showing 1 - 25 of >10,000
Acute Ischemic Stroke, Thrombocytopenia Trial (aspirin, clopidogrel, cilostazol, and dipyridamole)
Not yet recruiting
- Acute Ischemic Stroke
- Thrombocytopenia
- aspirin, clopidogrel, cilostazol, and dipyridamole
- (no location specified)
Sep 21, 2023
Intracranial Aneurysm, Stent Complication Trial (Ticagrelor monotherapy, Dual Antiplatelet Therapy)
Not yet recruiting
- Intracranial Aneurysm
- Stent Complication
- Ticagrelor monotherapy
- Dual Antiplatelet Therapy
- (no location specified)
Aug 23, 2023
Patients With Symptomatic Peripheral Arterial Disease
Recruiting
- Peripheral Arterial Disease
-
Leicester, United KingdomUniversity Hospitals Leicester
Sep 13, 2023
Elevated Lipoprotein(a) Level, Coronary Artery Disease, Drug-Eluting Stent Trial in Beijing (24 Months DAPT, 12 Months DAPT)
Not yet recruiting
- Elevated Lipoprotein(a) Level
- +3 more
- 24 Months DAPT
- 12 Months DAPT
-
Beijing, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Chi
Aug 26, 2023
Coronary Artery Disease, Coronary Artery Bypass Grafting, Dual Antiplatelet Therapy Trial in Beijing (De-escalated Dual
Recruiting
- Coronary Artery Disease
- +6 more
- De-escalated Dual Antiplatelet Therapy
- Dual Antiplatelet Therapy
-
Beijing, ChinaFuwai Hospital
Dec 13, 2022
Coronary Heart Disease Trial in Beijing (Ticagrelor, Clopidogrel, Aspirin)
Not yet recruiting
- Coronary Heart Disease
- Ticagrelor
- +2 more
-
Beijing, Beijing, ChinaFuwai Hospital
Oct 15, 2023
Aortic Stenosis, TAVI(Transcatheter Aortic Valve Implantation), Aspirin Trial in Shinjuku (Aspirin group, Non-antithrombotic
Recruiting
- Aortic Stenosis
- +4 more
- Aspirin group
- Non-antithrombotic group
-
Shinjuku, Tokyo, JapanKeio University Hospital
Aug 17, 2023
Dual Antiplatelet Therapy, Acute Coronary Syndrome, Coronary Artery Disease Trial in Messina, Rivoli (P2Y12 inhibitor
Not yet recruiting
- Dual Antiplatelet Therapy
- +2 more
- P2Y12 inhibitor de-escalation
-
Messina, Italy
- +1 more
Jun 12, 2023
Acute Ischemic Stroke, Atrial Fibrillation, Stenosis, Carotid Trial (Anticoagulant Oral, Anticoagulation combined with
Not yet recruiting
- Acute Ischemic Stroke
- +3 more
- Anticoagulant Oral
- Anticoagulation combined with antiplatelet therapy
- (no location specified)
Sep 21, 2023
MYOCARDIAL INFARCTION Trial in Paris (single-antiplatelet with a low-potency antiplatelet (aspirin or clopidogrel) guided by
Not yet recruiting
- MYOCARDIAL INFARCTION
- single-antiplatelet with a low-potency antiplatelet (aspirin or clopidogrel) guided by genetic testing.
-
Paris, IDF, FranceHopital Pitié Salpetrière
Jan 10, 2023
Intracranial Aneurysm Trial in Beijing (Adjustment of Antiplatelet Drugs)
Not yet recruiting
- Intracranial Aneurysm
- Adjustment of Antiplatelet Drugs
-
Beijing, Beijing, ChinaDepartment of Neurosurgery, Beijing Tiantan Hospital.
Apr 21, 2023
Atrial Fibrillation Trial in Warsaw (short postimplantation dual antiplatelet therapy, extended postimplantation dual
Recruiting
- Atrial Fibrillation
- short postimplantation dual antiplatelet therapy
- +3 more
-
Warsaw, Mazowieckie, PolandNational Institute of Cardiology
Dec 14, 2022
Coronary Artery Disease Trial (Angiolite: Sirolimus-eluting stent, Xience: Sirolimus-eluting stent, 1-month DAPT)
Not yet recruiting
- Coronary Artery Disease
- Angiolite: Sirolimus-eluting stent
- +3 more
- (no location specified)
Jul 11, 2023
Ischemic Stroke, Transient Ischemic Attack Trial in Singapore (Genetic testing)
Not yet recruiting
- Ischemic Stroke
- Transient Ischemic Attack
- Genetic testing
-
Singapore, SingaporeSingapore General Hospital
Mar 9, 2023
Acute Coronary Syndrome, Percutaneous Coronary Intervention, Dual Antiplatelet Therapy Trial in Wonju (Genoss DES™ stent)
Recruiting
- Acute Coronary Syndrome
- +2 more
- Genoss DES™ stent
-
Wonju, Gangwon State, Korea, Republic ofWonju Severance Christian Hospital
Oct 4, 2023
Coronary Artery Disease, Percutaneous Coronary Intervention Trial in Gainesville (DNA sample collection)
Recruiting
- Coronary Artery Disease
- Percutaneous Coronary Intervention
- DNA sample collection
-
Gainesville, FloridaUniversity of Florida
Nov 16, 2023
Atrial Fibrillation, Atrial Appendage, Anticoagulants Trial in Pessac, Toulouse (drug, device, other)
Recruiting
- Atrial Fibrillation
- +4 more
- Double antiplatelet therapy
- +3 more
-
Pessac, France
- +1 more
Oct 13, 2022
Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Coronary Artery Disease Trial in Bern (Algorithm-guided
Not yet recruiting
- Percutaneous Coronary Intervention
- +2 more
- Algorithm-guided DAPT duration
- Standard-of-care DAPT duration
-
Bern, SwitzerlandBern University Hospital
Feb 16, 2023
Coronary Artery Disease, Percutaneous Coronary Intervention, Dual Antiplatelet Therapy Trial in Wonju (Genoss DES™ stent)
Recruiting
- Coronary Artery Disease
- +2 more
- Genoss DES™ stent
-
Wŏnju, Gangwon State, Korea, Republic ofWonju Severance Christian Hospital
Oct 4, 2023
Acute Coronary Syndrome Trial in São Paulo (Dual antiplatelet therapy: Acetylsalicylic acid + ticagrelor OR Acetylsalicylic acid
Recruiting
- Acute Coronary Syndrome
- Dual antiplatelet therapy: Acetylsalicylic acid + ticagrelor OR Acetylsalicylic acid + prasugrel
- Monotherapy: Ticagrelor alone OR Prasugrel alone
-
São Paulo, BrazilHospital Israelita Albert Einstein
Mar 2, 2023
Left Ventricular Assist Device Patients
Completed
- End-stage Heart Failure
- +2 more
- VerifyNow antiplatelet therapy response test
-
Vienna, AustriaMedical University of Vienna
Nov 28, 2023
Tracheotomy With and Without Dual Antiplatelet Therapy
Recruiting
- Tracheostomy Hemorrhage
- Tracheotomy
-
Nidda, GermanyNeurologische Klinik Bad Salzhausen
Oct 29, 2022
Hereditary Hemorrhagic Telangiectasia, Rendu Osler Disease Trial in Clermont-Ferrand (monitoring the use of anticoagulant and/or
Not yet recruiting
- Hereditary Hemorrhagic Telangiectasia
- Rendu Osler Disease
- monitoring the use of anticoagulant and/or antiplatelet therapy in patients with osler rendering disease
-
Clermont-Ferrand, FranceCHU clermont-ferrand
Nov 29, 2022
Acute Coronary Syndrome Trial in Kyoto (No aspirin, 1-month DAPT)
Recruiting
- Acute Coronary Syndrome
- No aspirin
- 1-month DAPT
-
Kyoto, JapanKyoto University Graduate School of Medicine
Nov 16, 2022